Original Article
You have full text access to this OnlineOpen article
Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosine
Article first published online: 20 FEB 2002
DOI: 10.1002/ajh.10053
Copyright © 2002 Wiley-Liss, Inc.
Additional Information
How to Cite
Rodriguez-Galindo, C., Kelly, P., Jeng, M., Presbury, G. G., Rieman, M. and Wang, W. (2002), Treatment of children with Langerhans cell histiocytosis with 2-chlorodeoxyadenosine. Am. J. Hematol., 69: 179–184. doi: 10.1002/ajh.10053
Publication History
- Issue published online: 20 FEB 2002
- Article first published online: 20 FEB 2002
- Manuscript Accepted: 15 OCT 2001
- Manuscript Received: 12 APR 2001
Funded by
- American Lebanese Syrian Associated Charities (ALSAC).
- Abstract
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , Pediatric histiocytic sarcoma clonally related to precursor B-cell acute lymphoblastic leukemia with homozygous deletion of CDKN2A encoding p16INK4A, Pediatric Blood & Cancer, 2011, 56, 2Direct Link:
- 2, , , , , , , , , , Outcome of pediatric patients with Langerhans cell histiocytosis treated with 2 chlorodeoxyadenosine: a nationwide survey in Japan, International Journal of Hematology, 2010, 91, 4, 646
- 3, , , , , , , , , , 2′-chlorodeoxyadenosine (2-CdA) as salvage therapy for Langerhans cell histiocytosis (LCH). results of the LCH-S-98 protocol of the histiocyte society, Pediatric Blood & Cancer, 2009, 53, 7Direct Link:
- 4, , , Perianal Langerhans cell histiocytosis relieved by surgical excision, British Journal of Dermatology, 2009, 160, 1Direct Link:
- 5, , , , Successful treatment of central nervous system juvenile xanthogranulomatosis with cladribine, Pediatric Blood & Cancer, 2009, 52, 3Direct Link:
- 6, , Treatment of Refractory Langerhans Cell Histiocytosis (LCH) With a Combination of 2-Chlorodeoxyadenosine and Cytosine Arabinoside, Journal of Pediatric Hematology/Oncology, 2009, 31, 1, 53
- You have free access to this content7, , , , , , , , Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine, Pediatric Blood & Cancer, 2008, 50, 1Direct Link:
- 8, , , , , Clofarabine in refractory Langerhans cell histiocytosis, Pediatric Blood & Cancer, 2008, 51, 5Direct Link:
- 9, , , , , Extranodal multifocal RosaiâDorfman disease: response to 2-chlorodeoxyadenosine treatment, International Journal of Hematology, 2008, 89, 1, 58
- 10, , , , , , , Langerhans cell histiocytosis, Clinical and Translational Oncology, 2008, 10, 11, 688
- 11, , , , , , Isolated Langerhans cell histiocytosis of the vulva: a case report and review of the literature, Gynecological Surgery, 2007, 5, 2, 165
- 12, , , Langerhans' cell histiocytosis with multisystem involvement in an adult, Clinical and Experimental Dermatology, 2007, 32, 6Direct Link:
- 13
- 14, , , , , , Sinus histiocytosis with massive lymphadenopathy (Rosai–Dorfman disease) treated with 2-chlorodeoxyadenosine, Pediatric Blood & Cancer, 2006, 47, 5Direct Link:
- 15, , , , , , Treatment of recurrent Langerhans cell histiocytosis in children with 2-chlorodeoxyadenosine, Leukemia & Lymphoma, 2006, 47, 9, 1881
- 16, , Getting there? Salvage therapy for refractory Langerhans cell histiocytosis in children, European Journal of Cancer, 2005, 41, 17, 2592
- 17, , , , , , , , , , , Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction, European Journal of Cancer, 2005, 41, 17, 2682
- 18, , , , Predictors of outcome in children with Langerhans cell histiocytosis, Pediatric Blood & Cancer, 2005, 45, 1Direct Link:
- 19, , , , , Efficacy of continuous infusion 2-CDA (cladribine) in pediatric patients with Langerhans cell histiocytosis, Pediatric Blood & Cancer, 2004, 43, 1Direct Link:
- 20, , , , , , Extranodal Rosai-Dorfman Disease in Children, Journal of Pediatric Hematology/Oncology, 2004, 26, 1, 19
- 21, Histiocytoses,Direct Link:

1096-8652/asset/olbannerleft.gif?v=1&s=d9288d4b31f0b8e9a1eb2d195cb165e0aa1d7a97)
1096-8652/asset/olbannerright.gif?v=1&s=78488ac502104a3d829e729353def6ce62dc1e29)
1096-8652/asset/cover.gif?v=1&s=d31a603f9c7a1894ee3b68044c6fdcbe64ff8068)